The rank of natriuretic peptides NT-pro-BNP and BNP for the estimation of left-ventricular volume and function: A prospective study with 150 patients;Stellenwert der natriuretischen peptide NT-pro-BNP und BNP für die beurteilung der linksventrikulären größe und funktion: Eine prospektive untersuchung an 150 patienten

Deutsche Medizinische Wochenschrift

Volumn 127, Issue 49, 2002, Pages 2605-2609

  Pfister, R ^a   Scholz, M ^a   Wielckens, K ^a   Erdmann, E ^a   Schneider, Christian Alfons ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HORMONE PRECURSOR; PROBRAIN NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEMODYNAMIC MONITORING; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIDE ANALYSIS; PREDICTION; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 18744367796     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35931     Document Type: Article

References (26)

1. Bettencourt P, Ferreira A et al. Clinical significance of brain natriuretic peptide in patients with postmyocardial infarction. Clin Cardiol 2000; 23: 921-927
2. Campbell DJ, Mitchelhill KI, Schlicht SM, Booth RJ. Plasma amino-terminal pro-brain natriuretic peptide. J Card Fail 2000; 6: 130-139
3. Cowie MR et al. Incidence and aetiology of heart failure. Eur Heart J 1999; 20: 421-8
4. Hammerer-Lercher A et al. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 2001; 310: 193-7
5. Hirata Y, Matsumoto A, Aoyagi T et al. Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload. Cardiovasc Res 2001; 51: 585-591
6. Hunt PJ, Richards AM et al. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP) Clin Endocrinol (Oxf) 1997; 47: 287-296
7. Jensen KT, Carstens J et al. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Scand J Clin Lab Invest 1997; 57: 529-540
8. Karl J et al. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest 1999; 230 (Suppl); 177-181
9. Lubien E, DeMaria A, Krishnaswamy P et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction. Circulation 2002; 105: 595-601
10. McClure SJ et al. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. BMJ 1998; 317: 516-519
11. McDonagh TA, Robb SD, Murdoch DR et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998; 351: 9-13
12. McNairy M, Gardetto N et al. Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure. Am Heart J 2002; 143: 406-411
13. Nielsen OW et al. Risk assessment of left ventricular systolic dysfunction in primary care. BMJ 2000; 320: 220-224
14. Omland T, Aakvaag A, Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 1996; 76: 232-237
15. Qi W, Mathisen P, Kjekshus J et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J 2001; 142: 725-732
16. Richards AM, Nicholls MG et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin. Circulation 1998; 97: 1921-1929
17. Richards AM et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. Heart 1999; 81: 114-120
18. Smith H, Pickering RM et al. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice. BMJ 2000; 320: 906-908
19. Smith RA. Breast cancer screening among women younger than age 50: A current assessment of the issues. CA Cancer J Clin 2000; 50: 312-336
20. Steinhelper ME. Structure, expression, and genomic mapping of the mouse natriuretic peptide type-B gene. Circ Res 1993; 72: 984-992
21. Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989; 261: 884-888
22. Stewart S et al. Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001; 3: 315-322
23. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332: 78-81
24. The Cardiac Insufficiency Bisoprolol Study II. (CIBIS-II). Lancet 1999; 353: 9-13
25. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-691
26. Tsutamoto T et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Eur Heart J 1999; 20: 1799-1807